Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
P. Potemski
Observed name:
Piotr Potemski
Institution:
Medical University of Lodz
Observed institutions:
Copernicus Memorial Hospital,
Medical University of Lodz
ORCID:
0000-0001-7573-7347
Observed ORCID:
0000-0001-7573-7347
OpenAlex ID:
A5031229290
Perioperative durvalumab plus fluorouracil, leucovorin, oxaliplatin, and docetaxel for resectable gastric and gastro-oesophageal junction adenocarcinoma (MATTERHORN): final results of overall survival and event-free survival by pathological response in a global, randomised, double-blind, placebo-controlled, multicentre, phase 3 trial
2026
·
Yelena Y Janjigian
, Salah-Eddin Al-Batran
, et al.
·
The Lancet
·
7
86P Outcomes by primary tumour location in patients with advanced biliary tract cancer treated with durvalumab or placebo plus gemcitabine and cisplatin in the phase III TOPAZ-1 study
2022
·
A.R. He
, J.W. Valle
, et al.
·
Annals of Oncology
·
4
A Comparative Analysis of Quality of Life in Women Diagnosed with Breast and Ovarian Cancer
2022
·
Marta Dąbrowska-Bender
, Robert Słoniewski
, et al.
·
International Journal of Environmental Research and Public Health
·
4
PDF
O-1 Outcomes by primary tumour location in patients with advanced biliary tract cancer treated with durvalumab or placebo plus gemcitabine and cisplatin in the phase 3 TOPAZ-1 study
2022
·
A. He
, J. Valle
, et al.
·
Annals of Oncology
·
3
Retrospective Analysis of Regorafenib Efficiency in Treatment of Metastatic Colorectal Cancer—Experience of Two Polish Comprehensive Cancer Centers
2026
·
Magdalena Grabiec
, Dominika Raźniewska
, et al.
·
Journal of Clinical Medicine
PDF
Show more works
View as search
Works count:
5
Citation count:
18
H-index:
3
I10-index:
Year
Topic
Type